These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2093305)

  • 1. [Renin-angiotensin-aldosterone system in arterial hypertension].
    Kohlmann Júnior O
    Arq Bras Cardiol; 1990 Aug; 55 Suppl A():A3-5. PubMed ID: 2093305
    [No Abstract]   [Full Text] [Related]  

  • 2. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
    Rubattu S; Volpe M; Raman V; Lindpaintner K
    Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of the renin-angiotensin-aldosterone system and immunologic parameters in essential and symptomatic arterial hypertension].
    Shulutko BI; Baliasnikova TN
    Klin Med (Mosk); 1993; 71(6):24-7. PubMed ID: 8145496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
    Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL
    Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system as a mediator of renal injury in hypertension.
    Gharavi A; Klotman P
    Mt Sinai J Med; 1998 Mar; 65(2):118-24. PubMed ID: 9520515
    [No Abstract]   [Full Text] [Related]  

  • 9. [The renin-angiotensin system].
    De Leeuw PW
    Ter Arkh; 1997; 69(8):69-72. PubMed ID: 9381400
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tissue angiotensin II and its impact in the treatment of arterial hypertension].
    Escobar-Morreale HF; González Albarrán O; García Robles R
    Med Clin (Barc); 1997 Jan; 108(3):105-8. PubMed ID: 9064431
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the renin-angiotensin-aldosterone system during graduated ergometric tests in patients with essential arterial hypertension and in normal controls].
    Marchezotti AV; Feldstein CA; Leber B; Burucúa JE; Vilches AM; Varela de Rodríguez J
    Rev Clin Esp; 1981 May; 161(3):145-8. PubMed ID: 7022582
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North].
    Iakovlev VA; Sokol LIu; Karlov VA
    Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
    Soldner A; Spahn-Langguth H; Mutschler E
    Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression and function of vascular alpha1D-adrenoceptors may mediate the prohypertensive effects of angiotensin II.
    Villalobos-Molina R; Ibarra M
    Mol Interv; 2005 Dec; 5(6):340-2. PubMed ID: 16394249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
    Seravalle G; Cattaneo BM; Giannattasio C; Perondi R; Saino A; Grassi G; Mancia G
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S13-8. PubMed ID: 8230084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-angiotensin system and hypertension.
    Williams GH
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():31-40. PubMed ID: 6754184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.